PRKAG2 and atrial fibrillation: Another PRKAG2 mutation affecting the same amino acid (p. Val336Ala) was identified in a Caucasian family [7], displaying a severe cardiac phenotype, characterized by paroxysmal atrial fibrillation (AF), atrioventricular block and massive LVH, associated with SCD.